Delivery Order SPE2DB20D1100-SPE2DB25FD4S8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,907.49 firm fixed-price delivery order is for the supply of KENGREAL 50 MG VIALS medical products. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,442.86 firm fixed price delivery order is for the supply of KENGREAL 50 MG VIALS, with an ultimate completion date of October 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,309.04, is a Firm Fixed Price Delivery Order for the medical product KENGREAL 50 MG VIALS. The award has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $6,207.65 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of KENGREAL 50 MG VIALS, a specialized cardiovascular medication. The contract has an ultimate completion date of December 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,100.56 firm-fixed-price delivery order is for the supply of KENGREAL 50 MG VIALS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of July 25, 2022 and was awarded on July 22, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,357.27 contract is for the supply of 4,568,120,080 vials of the medication KENGREAL 50 MG. The delivery order has an ultimate completion date of May 5, 2025. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,858.56 firm-fixed-price delivery order is for the supply of 4556791245 KENGREAL 50 MG VIALS, with an ultimate completion date of April 6, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within military and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,494.65 firm fixed price contract is for the supply of KENGREAL 50 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $14,678.52 placed under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the procurement of 4,565,563,515 vials of the medication KENGREAL 50 MG. This IDC, worth up to $999,999,999 and running through November 2026, serves as a primary vehicle for Amerisourcebergen to provide a...
- <p>The Defense Logistics Agency awarded a $43,248 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562100543 KENGREAL 50 MG VIALS. To be performed in Conshohocken, Pennsylvania from September 8-11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order supports DLA's logistical requirements for specified drug products. No subcontractors or set aside designations were indicated.</p>
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD4S8Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KENGREAL 50 MG VIALS, a medical product, with a ceiling value of $36,687.78 and a completion date of July 17, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.7k | 7/16/25 |